Local Institution - 0028

Porto Alegre, Rio Grande do Sul 91350-200

1 studies enrolling now · 2 studies all time

What they study most

Pulmonary Fibrosis, Renal Cell Carcinoma

Studies at this site

• Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis — Starting soon
• A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread — Completed